Ginsenoside CK targets PHD2 to prevent platelet adhesion and enhance blood circulation by modifying the three-dimensional arrangement of collagen
Authors:
- Chuanjing ChengCCChuanjing Cheng
- Kaixin LiuKLKaixin Liu
- Jinling ZhangJZJinling Zhang
- Yanqi HanYHYanqi Han
- Tiejun ZhangTZTiejun Zhang
- Yuanyuan HouYHYuanyuan Hou
- Gang BaiGBGang Bai
Open Access
- 1 January 2025
- journal article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (3) , 1497-1513
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82274184)
This publication has 54 references indexed in Scilit:
- Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathwayInflammopharmacology, 2022
- Engineered platelets-based drug delivery platform for targeted thrombolysisActa Pharmaceutica Sinica B, 2022
- Daprodustat: First ApprovalDrugs, 2020
- Vadadustat: First ApprovalDrugs, 2020
- Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet AggregationThe Journal of Clinical Pharmacology, 2020
- Roxadustat: First Global ApprovalDrugs, 2019
- Integrated metabolomic and transcriptomic analyses revealed the distribution of saponins in Panax notoginsengActa Pharmaceutica Sinica B, 2018
- Screening of anti‐platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC–DAD–ESI‐MS/MSJournal of Separation Science, 2008
- A fluorescence-based assay for 2-oxoglutarate-dependent oxygenasesAnalytical Biochemistry, 2005
- Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary SyndromesJAMA, 2000